La Jolla, CA, United States of America

Matthew Weitzman

This inventor holds 2 USPTO granted patents. Top assignee: University of Pennsylvania. Active years: 1999-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Weitzman. Retrieved from https://idiyas.com/inventor/matthew-weitzman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Matthew Weitzman

Introduction

Matthew Weitzman is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of virology, particularly in the development of adenoviral technologies. With a total of 2 patents, his work has implications for therapeutic applications and research.

Latest Patents

One of his latest patents is focused on adenoviruses and methods of use thereof. This patent describes a recombinant adenovirus and a method for producing the virus, utilizing a recombinant shuttle vector that comprises adenovirus DNA sequences necessary for replication and virion encapsidation. The invention also includes a helper adenovirus with modified packaging sequences, which facilitates the purification of viral particles from the helper virus.

Career Highlights

Matthew Weitzman is affiliated with the University of Pennsylvania, where he continues to advance research in the field of gene therapy and viral vectors. His innovative approaches have garnered attention in both academic and clinical settings.

Collaborations

He has collaborated with notable colleagues such as James M. Wilson and Krishna J. Fisher, contributing to a rich environment of research and development.

Conclusion

Matthew Weitzman's work exemplifies the intersection of innovation and practical application in the field of virology. His contributions continue to pave the way for advancements in therapeutic techniques and research methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…